Goat Anti-Ephrin B2 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-LAP1 Monoclonal Antibody, Unconjugated, Clone RL13 from Abcam
Sheep Anti-Pig Malate Dehydrogenase Polyclonal Antibody, Unconjugated from Abcam
TaqMan Rodent GAPDH Control Reagents from Applied Biosystems
Biology Products:(Date:12/1/2009)...4-year veteran of the high-technology industry, ha...development and intellectual property management c...e. The company also plans to invest in promising .... , Monterey, CA (PRWEB) ...veteran of the high-technology industry, has forme...
(Date:11/30/2009)...wire/ -- Acuo Technologies, developers of high-per...igration tools and services, today announced contr... Vendor Neutral Archive (VNA), providing the found...f hospitals, clinics and affiliates. ,, The arc...DICOM Services Grid(TM) Software. The Acuo VNA ar...
(Date:11/30/2009)...wire/ -- Biopharmaceutical company Kiadis,Pharma a...nrolled in its,multinational registration clinical...w reduction in transplant related mortality (TRM) ...ransplantation with a mismatched,(haplo-identical)...logeneic,stem cell transplantation but without hav...
(Date:11/30/2009)...FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq...dministration (FDA) has granted orphan drug design...dine phosphate, for the rare autoimmune disease La...as previously received orphan drug designation in ... Medicinal Products for Human Use of the European ...
Breaking Biology Technology:Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 2Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 4Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 3Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4